Compare CVS Health Corp (CVS) vs SYSCO Corporation (SYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs SYSCO Corporation — how do they compare? CVS Health Corp trades at $86.01 (market cap $112.29B), while SYSCO Corporation trades at $78.07 (market cap $38.47B). The key difference: CVS Health Corp is far larger — about 2.9× SYSCO Corporation's market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and SYSCO Corporation for 77 Days on average.
| CVS | SYY | |
|---|---|---|
Market Cap | $112.29B | $38.47B |
Volume | 7,763,676 | 4,808,465 |
Sector | Health | Consumer Staples |
52-Week High | $110.60 | $91.16 |
52-Week Low | $70.08 | $69.30 |
Typical Hold Time | 83 Days | 77 Days |
Enterprise Value | $174.64B | $51.65B |
Dividend Yield | 3.03% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
Sysco (SYY) trades at $76.79, down 0.85% on the day, with a bearish technical signal despite recent earnings beats. The company maintains steady revenue growth, reaching $81.37B in 2025, though net margins remain thin at 2.08%. Recent developments include a $500M AI efficiency program and a $1.5B senior notes offering, positioning for future growth while managing debt levels near 50% of assets.
Outlook remains cautiously optimistic with 60% analyst buy ratings and an $85.75 price target suggesting 12% upside. Key risks include margin pressure from inflation and competitive threats, while the AI initiative and consistent dividend payments provide stability. The stock offers value at a P/S of 0.44 but requires monitoring of debt management and execution on efficiency targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About SYSCO Corporation
Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →
